Coca-Cola (KO) Stock on November 30, 2025: Dividend Deadline, Buffett Backing and New Price Forecasts

As November closes, Coca-Cola Co. heads into December trading near its highs for the year, with a fresh dividend cutoff, strong third-quarter earnings, heavy options activity and a stream of new analyst and media coverage shaping sentiment around the stock.

Bristol-Myers Squibb (BMY) Stock on November 29, 2025: 5.4% Dividend, Heavy Institutional Buying and a ‘Hold’ Consensus

Bristol-Myers Squibb (BMY) Stock on November 29, 2025: 5.4% Dividend, Heavy Institutional Buying and a ‘Hold’ Consensus

Bristol-Myers Squibb spent Saturday, November 29, 2025 out of the trading spotlight—U.S. markets were closed—but very much in the headlines. A cluster of fresh reports focused on three themes: a fat 5.4% dividend yield, big institutional investors quietly adding to their positions, and a Wall Street analyst community that largely refuses to move beyond a “Hold” stance on the stock. Nasdaq+2MarketBeat+2
30 November 2025
PayPal (PYPL) Stock on November 29, 2025: Big-Money Buying, AI Deals, BNPL Expansion and a New Dividend

PayPal (PYPL) Stock on November 29, 2025: Big-Money Buying, AI Deals, BNPL Expansion and a New Dividend

PayPal Holdings, Inc. enters the final stretch of 2025 as one of the market’s most hotly debated fintech stocks. The share price is down sharply for the year, yet a wave of institutional money, a landmark AI partnership with OpenAI, a renewed multi‑billion‑euro BNPL deal with KKR, and the company’s first-ever dividend are all reshaping the investment story.
Johnson & Johnson (JNJ) Stock Near Record Highs: Today’s News, Earnings, Dividend and Talc Risks – November 29, 2025

Johnson & Johnson (JNJ) Stock Near Record Highs: Today’s News, Earnings, Dividend and Talc Risks – November 29, 2025

On November 29, 2025, Johnson & Johnson sits close to record territory after a powerful year-long rally, with Wall Street increasingly treating the healthcare giant as both a growth and defensive name at the same time. The stock is hovering around the $206–$207 range after Friday’s U.S. close, not far from a recent 12‑month high near $207.81 and above the late‑November all‑time closing high around $203.48.Investing.com+1
AbbVie Stock (ABBV) Today: Skyrizi’s Canada Win, Dividend Hike and Big-Money Moves — November 28, 2025

AbbVie Stock (ABBV) Today: Skyrizi’s Canada Win, Dividend Hike and Big-Money Moves — November 28, 2025

AbbVie Inc. ended Friday’s session almost unchanged, closing around $227.70 per share, up a negligible 0.02%, after earlier trading slightly in the red.StockAnalysis+2StockAnalysis+2 Even with today’s flat finish, the pharma giant remains one of 2025’s standout healthcare names, with year‑to‑date gains of roughly 30–33%, easily beating the S&P 500.Investing.com+1
28 November 2025
Imperial Brands (LON: IMB) Share Price on 28 November 2025: Ex‑Dividend, Analyst Upgrades and New ‘Zone’ Nicotine Pouch Launch

Imperial Brands (LON: IMB) Share Price on 28 November 2025: Ex‑Dividend, Analyst Upgrades and New ‘Zone’ Nicotine Pouch Launch

Imperial Brands PLC stock is back in focus on Friday 28 November 2025 as the FTSE 100 tobacco group trades close to 12‑month highs, digests a fresh dividend, and rolls out its latest nicotine pouch brand in the UK. At the same time, a run of analyst upgrades and a larger share buyback are reshaping the investment case around one of London’s highest‑yielding blue chips. Google+2Investing.com+2
1 38 39 40 41 42 46